Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL2290380

CC.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA7 P43166 2/20 0.41
CA13 Q8N1Q1 1/20 0.41
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
CA5A P35218 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
F2 P00734 2/20 0.35
PRSS1 P07477 2/20 0.35
PRSS2 P07478 2/20 0.35
PRSS3 P35030 2/20 0.35
EPHX1 P07099 1/20 0.32
NT5E P21589 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL27964313 0.92 ALDH1A1 (0.45) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL28243370 0.92 ALDH1A1 (0.45) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL9460589 0.92 ALDH1A1 (0.45) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL295 0.92
Trifluoromethanesulfonic Acid SCHEMBL39465 0.92 ALDH1A1 (0.50) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL3950101 0.92
Trifluoromethanesulfonic Acid SCHEMBL3507077 0.92
Trifluoromethanesulfonic Acid SCHEMBL1750663 0.89 CA2 (0.45) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL336431 0.89 ALDH1A1 (0.43) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL3292155 0.89 ALDH1A1 (0.43) ALDH1A1L3MBTL1CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3905410-B1 COMPOSITE SEPARATING LAYER PROLOGIUM TECH CO LTD (TW) 2025-05-07 EP disclosed
US-12272796-B2 Lithium battery structure and electrode layer thereof PROLOGIUM TECHNOLOGY CO., LTD. (TW) 2025-04-08 US disclosed
CN-112701346-B Solid electrolyte contact surface conditioning material and mixed electrolyte system thereof 辉能科技股份有限公司 2025-03-11 CN disclosed
US-20240136596-A1 LITHIUM BATTERY STRUCTURE AND ELECTRODE LAYER THEREOF PROLOGIUM TECHNOLOGY CO., LTD. (TW) 2024-04-25 US disclosed
US-11881560-B2 Lithium battery structure and electrode layer thereof PROLOGIUM TECHNOLOGY CO., LTD. (TW) 2024-01-23 US disclosed
EP-3819960-B1 LITHIUM BATTERY STRUCTURE AND ELECTRODE LAYER THEREOF PROLOGIUM TECH CO LTD (TW) 2023-12-06 EP disclosed
CN-112787040-B Ceramic barrier layer 辉能科技股份有限公司 2023-03-24 CN disclosed
US-11495825-B2 Contact surface adjusting material for solid electrolytes and composite electrolyte system thereof PROLOGIUM TECHNOLOGY CO., LTD. (TW) 2022-11-08 US disclosed
US-8008007-B2 S-adenosyl-L-methionine analogs with extended activated groups for transfer by methyltransferases RWTH AACHEN (DE) 2011-08-30 US disclosed
EP-1874790-B1 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2010-08-18 EP disclosed
US-20090018101-A1 S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2009-01-15 US disclosed
EP-1874790-A2 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH Aachen (DE) 2008-01-09 EP disclosed
WO-2006108678-A2 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2006-10-19 WO disclosed
EP-1712557-A1 New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases RWTH Aachen (DE) 2006-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018101-A1 S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES BHMT2, MSRB3, PRMT3 ALDH1A1 1441/4885L3MBTL1 328/4885CA1 2302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.